Study to Evaluate Efficacy and Safety of BGB-3111 in Participants With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Clinical trial NCT03206970 · COMPLETED
Trial details
- NCT number
- NCT03206970
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-02
- Primary completion
- 2019-02-15
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.